Cargando…

Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signaling

BACKGROUND: Opioid and beta-adrenergic receptors are recently shown to cross talk via formation of receptor heterodimers to control the growth and proliferation of breast cancer cells. However, the underlying cell signaling mechanism remained unclear. METHODS: To determine the effect of the interact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rousseau, Bénédicte, Murugan, Sengottuvelan, Palagani, Ajay, Sarkar, Dipak K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107672/ https://www.ncbi.nlm.nih.gov/pubmed/35568869 http://dx.doi.org/10.1186/s13058-022-01526-y

Ejemplares similares

Beta 2 Adrenergic Receptor Antagonist Propranolol and Opioidergic Receptor Antagonist Naltrexone Produce Synergistic Effects on Breast Cancer Growth Prevention by Acting on Cancer Cells and Immune Environment in a Preclinical Model of Breast Cancer
por: Murugan, Sengottuvelan, et al.
Publicado: (2021)

Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to “Biased Opioids”?
por: Root-Bernstein, Robert, et al.
Publicado: (2018)

Hypothalamic beta-endorphin neurons suppress preneoplastic and neoplastic lesions development in 1,2-dimethylhydrazine induced rat colon cancer model
por: Murugan, Sengottuvelan, et al.
Publicado: (2017)

Glycogen Synthase Kinase 3 Beta Regulates the Human Aryl Hydrocarbon Receptor Cellular Content and Activity
por: Yang, Yujie, et al.
Publicado: (2021)

Mu-opioid receptor and delta-opioid receptor differentially regulate microglial inflammatory response to control proopiomelanocortin neuronal apoptosis in the hypothalamus: effects of neonatal alcohol
por: Shrivastava, Pallavi, et al.
Publicado: (2017)

The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
por: Yu, Honglu, et al.
Publicado: (2023)

Constitutive glycogen synthase kinase-3α/β activity protects against chronic β-adrenergic remodelling of the heart
por: Webb, Ian G., et al.
Publicado: (2010)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells
por: Mishra, Prajna, et al.
Publicado: (2010)

The Role of Beta-Adrenergic Receptors in Depression and Resilience
por: Zhang, Hongxing, et al.
Publicado: (2022)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Glycogen synthase kinase 3 beta: can it be a target for oral cancer
por: Mishra, Rajakishore
Publicado: (2010)

Deletion of Glycogen Synthase Kinase 3 Beta Reprograms NK Cell Metabolism
por: Pereira, Marcelo S. F., et al.
Publicado: (2023)

Transgenerational inheritance of fetal alcohol exposure adverse effects on immune gene interferon-ϒ
por: Gangisetty, Omkaram, et al.
Publicado: (2020)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?
por: Embaby, Alaa, et al.
Publicado: (2022)

Morphology of astroglial cells is controlled by beta-adrenergic receptors
Publicado: (1987)

The Principles of Ligand Specificity on beta-2-adrenergic receptor
por: Chan, H. C. Stephen, et al.
Publicado: (2016)

Beta-adrenergic receptors are expressed across diverse cancers
por: Rains, Steven L., et al.
Publicado: (2017)

Alpha and beta adrenergic receptors modulate keratinocyte migration
por: Yang, Hsin-ya, et al.
Publicado: (2021)

Dissecting Beta-Adrenergic Receptors: The Sum of Many Parts
por: Port, J. David
Publicado: (2023)

Beta(1)-Adrenergic Receptor Cleavage and Regulation by Elastase
por: Zhu, Jing, et al.
Publicado: (2023)

Mutual Enhancement of Opioid and Adrenergic Receptors by Combinations of Opioids and Adrenergic Ligands Is Reflected in Molecular Complementarity of Ligands: Drug Development Possibilities
por: Root-Bernstein, Robert, et al.
Publicado: (2019)

Mu opioid receptor: from pain to glucose metabolism
por: Tudurí, Eva, et al.
Publicado: (2016)

Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens
por: Cortés-Vieyra, Ricarda, et al.
Publicado: (2012)

Differential Roles of Glycogen Synthase Kinase 3 Subtypes Alpha and Beta in Cortical Development
por: Ma, Yan-xia, et al.
Publicado: (2017)

Quantification of Beta Adrenergic Receptor Subtypes in Beta-Arrestin Knockout Mouse Airways
por: Hegde, Akhil, et al.
Publicado: (2015)

Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer
por: Jorand, Raphael, et al.
Publicado: (2016)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014)

Activation of GABA(B) receptors inhibits protein kinase B /Glycogen Synthase Kinase 3 signaling
por: Lu, Frances Fangjia, et al.
Publicado: (2012)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_sueor9v3s8ks54b1ttf30uuteh